Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD

Journal of Nutritional Biochemistry

Volumn 23, Issue 7, 2012, Pages 817-821

  de Batlle, Jordi ^a,b,c,d   Sauleda, Jaume ^e,f,g   Balcells, Eva ^b,e   Gómez, Federico P ^e,h   Méndez, Michelle ^a,b,c   Rodriguez, Esther ⁱ   Barreiro, Esther ^b,d,e,j   Ferrer, Jaume J ^e,i   Romieu, Isabelle ^k   Gea, Joaquim ^b,d,e,j   Antó, Josep M ^a,b,c,d   Garcia Aymerich, Judith ^a,b,c,d  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^g Fundació Caubet Cimera ^*  (Spain)

^h INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^j URMAR   (Spain)

^k INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

more..

Author keywords

Food intake; Inflammation; Public health; Pulmonary disease, chronic obstructive

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; INTERLEUKIN 8; LINOLENIC ACID; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET RESTRICTION; DISEASE MARKER; DISEASE SEVERITY; FAT INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT;

AGED; ALPHA-LINOLENIC ACID; ARACHIDONIC ACID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LINOLEIC ACID; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862333858     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.04.005     Document Type: Article

References (29)

1. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:2011-2030.
2. Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) Date last accessed: July 15 2009. http://www.goldcopd.com.
3. Saetta M., Turato G., Facchini F.M., Corbino L., Lucchini R.E., Casoni G., et al. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med 1997, 156:1633-1639.
4. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
5. Hurst J.R., Perera W.R., Wilkinson T.M., Donaldson G.C., Wedzicha J.A. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:71-78.
6. Wouters E.F., Groenewegen K.H., Dentener M.A., Vernooy J.H. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 2007, 4:626-634.
7. Shaaban R., Kony S., Driss F., Leynaert B., Soussan D., Pin I., et al. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med 2006, 100:2112-2120.
8. Man S.F., Connett J.E., Anthonisen N.R., Wise R.A., Tashkin D.P., Sin D.D. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006, 61:849-853.
9. Dahl M., Vestbo J., Lange P., Bojesen S.E., Tybjaerg-Hansen A., Nordestgaard B.G. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175:250-255.
10. Schwartz J. Role of polyunsaturated fatty acids in lung disease. Am J Clin Nutr 2000, 71:393s-396s.
11. Smit H.A., Grievink L., Tabak C. Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence. Proc Nutr Soc 1999, 58:309-319.
12. Romieu I., Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001, 23:268-287.
13. Tai C.C., Ding S.T. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem 2010, 21:357-363.
14. Calder P.C., Grimble R.F. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 2002, 56:14s-19s.
15. Garcia-Aymerich J., Gómez F.P., Antó J.M. [Phenotypic characterization and course of chronic obstructive pulmonary disease (COPD) in the PAC-COPD study: design and methods]. Arch Bronconeumol 2009, 45:4-11. on behalf of the PAC-COPD Research Study Group.
16. Celli B.R., MacNee W., ATS/ERS Task Force Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
17. Balcells E., Antó J.M., Gea J., Gómez F.P., Rodríguez E., Marin A., et al. Characteristics of patients admitted for the first time for COPD exacerbation. Respir Med 2009, 103:1293-1302. PAC-COPD Study Group.
18. de Batlle J., Romieu I., Antó J.M., Mendez M., Rodríguez E., Balcells E., et al. Dietary habits of firstly admitted Spanish COPD patients. Respir Med 2009, 103:1904-1910. The PAC-COPD Study Group.
19. Martin-Moreno J.M., Boyle P., Gorgojo L., Maisonneuve P., Fernandez-Rodriguez J.C., Salvini S., et al. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993, 22:512-519.
20. U.S.Department of Agriculture, Agricultural Research Service USDA national nutrient database for standard reference Nutrient Data Laboratory Home Page. http://www.ars.usda.gov/nutrientdata.
21. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47:1245-1251.
22. Hosmer D.W., Lemeshow S. Applied logistic regression 1989, Wiley, New york.
23. Galli C., Calder P.C. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab 2009, 55:123-139.
24. Miedema I., Feskens E.J., Heederik D., Kromhout D. Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study. Am J Epidemiol 1993, 138:37-45.
25. Pischon T., Hankinson S.E., Hotamisligil G.S., Rifai N., Willett W.C., Rimm E.B. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108:155-160.
26. Russo G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009, 77:937-946.
27. Tanino M., Betsuyaku T., Takeyabu K., Tanino Y., Yamaguchi E., Miyamoto K., et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002, 57:405-411.
28. Knudsen L.S., Christensen I.J., Lottenburger T., Svendsen M.N., Nielsen H.J., Nielsen L., et al. Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis. Biomarkers 2008, 13:59-78.
29. Blair A., Saracci R., Vineis P., Cocco P., Forastiere F., Grandjean P., et al. Epidemiology, public health, and the rhetoric of false positives. Environ Health Perspect 2009, 117:1809-1813.